
Be the first to like this
Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our User Agreement and Privacy Policy.
Slideshare uses cookies to improve functionality and performance, and to provide you with relevant advertising. If you continue browsing the site, you agree to the use of cookies on this website. See our Privacy Policy and User Agreement for details.
Published on
With the help of 10year data span from 2007 to 2017, we will find out the intrinsic value in a different method and will compare it to the current share price of Orion Pharma and find out whether it is overvalued or undervalued.
The structure of the slide is in the following way
1. Introduction
2. Company Overview
3. Findings
5. Analysis
6. Conclusion
The total valuation was done in the following way
1. Dividend Discounting Model
2. Operating Free Cash Flow Model
3. Relative Valuation
The analysis is done with
1. Fundamental Analysis
Be the first to like this
Be the first to comment